Bioengineering and Translational Medicine
Published by John Wiley & Sons
eISSN : 2380-6761
Abbreviation : Bioeng. Transl. Med.
Aims & Scope
Bioengineering & Translational Medicine is an official, peer-reviewed, online, open access journal of the American Institute of Chemical Engineers (AIChE) and its technological community, the Society for Biological Engineering (SBE).
Bioengineering & Translational Medicine is focused on the fundamental ways chemical and biological engineering approaches drive and provide innovative technologies and solutions that impact clinical practice and/or commercial healthcare products.
The journal includes research reports, reviews, and rapid communications with a focus on biomolecular engineering advances.
Topics covered in Bioengineering & Translational Medicine include: - Drug delivery - Drug discovery and development - Tissue engineering - Chemical engineering-based bioprocessing - Synthetic biology - Biosensors - Organoids and organ-mimetic systems - Stem cell therapies - Gene therapies - Immunotherapies - Patient-targeted therapies - Medical devices - Regenerative medicine - Implant/patient interface - Compounds/materials - Nanobiology - Computational modeling - Bioinformatics
View Aims & ScopeMetrics & Ranking
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 1.478 |
Quartile
Year | Value |
---|---|
2024 | Q1 |
Impact Factor
Year | Value |
---|---|
2024 | 6.10 |
Journal Rank
Year | Value |
---|---|
2024 | 2456 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 2752 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Engineering and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology, Engineering and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.
This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,890.00 USD. Learn more.
Explore journals without APCs for alternative publishing options.